Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Blueprint Genetics | RCV000208441 | SCV000264271 | uncertain significance | Brugada syndrome | 2015-05-21 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000029159 | SCV000290315 | likely benign | Progressive familial heart block type IB | 2024-01-30 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001093252 | SCV000521223 | likely benign | not provided | 2020-03-31 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 26820365, 23382873, 20562447, 21887725, 27884173, 26350513, 28341588, 27207958, 22750058, 30021168) |
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000029159 | SCV000745390 | uncertain significance | Progressive familial heart block type IB | 2017-11-07 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000990240 | SCV001141118 | uncertain significance | Progressive familial heart block, type 1A | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000029159 | SCV001294174 | uncertain significance | Progressive familial heart block type IB | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Ambry Genetics | RCV002381261 | SCV002689562 | benign | Cardiovascular phenotype | 2018-12-03 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV004700279 | SCV005203363 | likely benign | not specified | 2024-07-21 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000029159 | SCV000051804 | pathogenic | Progressive familial heart block type IB | 2012-01-01 | no assertion criteria provided | literature only | |
Laboratory of Diagnostic Genome Analysis, |
RCV001093252 | SCV001799194 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV001093252 | SCV001919403 | uncertain significance | not provided | no assertion criteria provided | clinical testing |